I was more referencing the tweet which looked at the performance of a particular vintage of those funds: https://mobile.twitter.com/zavaindar/status/1159660549615116... none of which reached $1 billion vs the largest funds on the second page https://mobile.twitter.com/zavaindar/status/1159660549615116...

I look forward to seeing how the newer larger biotech funds do/seeing more recent data during a time where public tech outperformed rest of public market.